fda compounding semaglutide enforcement news november 2025 The has announced that it has given us an expedited review of the once-a-day weight loss pill we're investigating, potentially giving people living with obesity a new treatment option early next Compounded weight loss injections —

I forgot to pre-register my experiment, but my hypothesis was that if I took 2 mg [1] of retatrutide per week, I would lose weight

Approved medicines have prescribing labels, pharmacy supply chains, adverse-event reporting systems, and post-marketing safety information

The amount is up to you and your research protocol

Then you increase to 7 mg daily

When considering the science behind GLP-1s, this outcome aligns with expectations

Table of Contents Why GLP-1 Medications May Cause Increased Urination Common Urinary Side Effects of GLP-1 Receptor Agonists When Frequent Urination on GLP-1 Treatment Needs Medical Attention Managing Increased Urination While Taking GLP-1 Medications Other Factors That May Affect Urination During GLP-1 Therapy Scientific References Frequently Asked Questions Why GLP-1 Medications May Cause Increased Urination GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), are increasingly prescribed for type 2 diabetes management and weight loss